[Federal Register Volume 59, Number 150 (Friday, August 5, 1994)]
[Unknown Section]
[Page 0]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 94-19109]


[[Page Unknown]]

[Federal Register: August 5, 1994]


-----------------------------------------------------------------------


SECURITIES AND EXCHANGE COMMISSION
 

Issuer Delisting; Application To Withdraw From Listing and 
Registration; (Maxxim Medical, Inc., Common Stock, $.001 Par Value; 
6\3/4\% Convertible Subordinated Debentures Due 2003) File No. 1-10600

August 1, 1994.
    Maxxim Medical, Inc. (``Company'') has filed an application with 
the Securities and Exchange Commission (``Commission''), pursuant to 
Section 12(d) of the Securities Exchange Act of 1934 (``Act'') and Rule 
12d2-2(d) promulgated thereunder, to withdraw the above specified 
securities from listing and registration on the American Stock 
Exchange, Inc. (``Amex'').
    The reasons alleged in the application for withdrawing these 
securities from listing and registration include the following:
    According to the Company, in addition to being listed on the Amex, 
its common stock and convertible subordinated debentures are listed on 
the New York Stock Exchange, Inc. (``NYSE''). The Company's common 
stock and 6\3/4\% Convertible Subordinated Debentures commenced trading 
on the NYSE at the opening of business on December 22, 1993 and 
concurrently therewith such stock was suspended from trading on the 
Amex.
    In making the decision to withdraw its Common Stock and 6\3/4\% 
Convertible Subordinated Debentures from listing on the Amex, the 
Company considered the direct and indirect costs and expenses attendant 
in maintaining the dual listing of its Common Stock and 6\3/4\% 
Convertible Subordinated Debentures on the NYSE and on the Amex. The 
Company does not see any particular advantage in the dual trading of 
its Common Stock and 6\3/4\% Convertible Subordinated Debentures and 
believes that dual listing would fragment the market for the Common 
Stock and 6\3/4\% Convertible Subordinated Debentures.
    Any interested person may, on or before August 22, 1994 submit by 
letter to the Secretary of the Securities and Exchange Commission, 450 
Fifth Street, NW., Washington, DC 20549, facts bearing upon whether the 
application has been made in accordance with the rules of the exchanges 
and what terms, if any, should be imposed by the Commission for the 
protection of investors. The Commission, based on the information 
submitted to it, will issue an order granting the application after the 
date mentioned above, unless the Commission determines to order a 
hearing on the matter.

    For the Commission, by the Division of Market Regulation, 
pursuant to delegated authority.
Jonathan G. Katz,
Secretary.
[FR Doc. 94-19109 Filed 8-4-94; 8:45 am]
BILLING CODE 8010-01-M